122 related articles for article (PubMed ID: 6314723)
1. Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease.
Koppeschaar HP; Croughs RJ; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1983 Oct; 104(2):160-3. PubMed ID: 6314723
[TBL] [Abstract][Full Text] [Related]
2. Response to neurotransmitter modulating drugs in patients with Cushing's disease.
Koppeschaar HP; Croughs RJ; Thijssen JH; Schwarz F
Clin Endocrinol (Oxf); 1986 Dec; 25(6):661-7. PubMed ID: 3115630
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with sodium valproate of a patient with Cushing's disease and gross enlargement of the pituitary.
Koppeschaar HP; Croughs RJ; van't Verlaat JW; Hendriks MJ; Arts CJ; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1984 Dec; 107(4):471-5. PubMed ID: 6097074
[TBL] [Abstract][Full Text] [Related]
4. Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation.
Tucci JR; Nowakowski KJ; Jackson IM
J Endocrinol Invest; 1989 Mar; 12(3):197-200. PubMed ID: 2542391
[TBL] [Abstract][Full Text] [Related]
5. The effect of cyproheptadine and/or bromocriptine on plasma ACTH levels in patients cured of Cushing's disease by bilateral adrenalectomy.
Whitehead HM; Beacom R; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 1990 Feb; 32(2):193-201. PubMed ID: 2161298
[TBL] [Abstract][Full Text] [Related]
6. The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease.
Reincke M; Allolio B; Kaulen D; Jaursch-Hancke C; Winkelmann W
Klin Wochenschr; 1988 Aug; 66(15):686-9. PubMed ID: 2845188
[TBL] [Abstract][Full Text] [Related]
7. [Effect of cyproheptadine on plasma ACTH and cortisol secretion in a patient with Cushing's disease].
Esposito V; D'Alessandro B; Bellastella A; Iacono G; Bizzarro A; Officioso A; Piccolo C
Boll Soc Ital Biol Sper; 1976 Nov; 52(22):1901-5. PubMed ID: 194608
[No Abstract] [Full Text] [Related]
8. Bromocriptine-responsive Cushing's disease associated with anterior pituitary corticotroph hyperplasia or normal pituitary gland.
Croughs RJ; Koppeschaar HP; van't Verlaat JW; McNicol AM
J Clin Endocrinol Metab; 1989 Feb; 68(2):495-8. PubMed ID: 2537335
[TBL] [Abstract][Full Text] [Related]
9. [Clinical remission in Cushing's disease through treatment with sodium valproate and bromocriptine].
García Rojas JF; Mangas Rojas A; Barba Chacón A; García Osle M; Zamora Madaria E
Rev Clin Esp; 1991 Jan; 188(1):37-40. PubMed ID: 2063025
[TBL] [Abstract][Full Text] [Related]
10. Cyproheptadine-induced remission of Cushing's disease due to pituitary basophil adenoma.
Jimenez-Alonso J; Munoz-Avila J; Jaimez L; Pérez-Jimenez F; Bellido C; Jiménez-Perepérez JA
Drug Intell Clin Pharm; 1982 Dec; 16(12):962-5. PubMed ID: 6295736
[TBL] [Abstract][Full Text] [Related]
11. The effect of sodium valproate on plasma ACTH and cortisol concentrations in Cushing's disease and Nelson's syndrome.
Kasperlik-Załuska A; Drac-Kaniewska J; Migdalska B; Jeske W; Wiśniewska-Woźniak T
Endokrynol Pol; 1988; 39(5):245-52. PubMed ID: 2855625
[No Abstract] [Full Text] [Related]
12. Cyproheptadine in the control of Cushing's disease.
Hsu TH; Gann DS; Tsan KW; Russell RP
Johns Hopkins Med J; 1981 Aug; 149(2):77-83. PubMed ID: 6265685
[TBL] [Abstract][Full Text] [Related]
13. [Use of cyproheptadine in the treatment of Cushing's disease].
Jannì A; Carmina E; Lanzara P; Lo Coco R; Longo RA
Clin Ter; 1979 Feb; 88(4):345-54. PubMed ID: 222530
[No Abstract] [Full Text] [Related]
14. Five cases of cyclical Cushing's syndrome.
Atkinson AB; Kennedy AL; Carson DJ; Hadden DR; Weaver JA; Sheridan B
Br Med J (Clin Res Ed); 1985 Nov; 291(6507):1453-7. PubMed ID: 2998540
[TBL] [Abstract][Full Text] [Related]
15. Failure of long-term therapy with sodium valproate in Cushing's disease.
Colao A; Pivonello R; Tripodi FS; Orio F; Ferone D; Cerbone G; Di Somma C; Merola B; Lombardi G
J Endocrinol Invest; 1997; 20(7):387-92. PubMed ID: 9309536
[TBL] [Abstract][Full Text] [Related]
16. Six year remission of ACTH-dependent Cushing's syndrome using bromocriptine.
Atkinson AB; Kennedy AL; Sheridan B
Postgrad Med J; 1985 Mar; 61(713):239-42. PubMed ID: 2984649
[TBL] [Abstract][Full Text] [Related]
17. The relationship between cortisol and ACTH in patients with Cushing's disease following neurosurgery or pharmacotherapy.
Kasperlik-Załuska A; Migdalska B; Jeske W; Wiśniewska-Woźniak T; Sek S
Endokrynol Pol; 1989; 40(2):63-7. PubMed ID: 2560712
[No Abstract] [Full Text] [Related]
18. The combined use of sodium valproate and metyrapone in the treatment of Cushing's syndrome.
Nussey SS; Price P; Jenkins JS; Altaher AR; Gillham B; Jones MT
Clin Endocrinol (Oxf); 1988 Apr; 28(4):373-80. PubMed ID: 2847889
[TBL] [Abstract][Full Text] [Related]
19. Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma.
Ooi TC; Twum-Barima Y
J Endocrinol Invest; 1987 Apr; 10(2):107-9. PubMed ID: 3584851
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome.
Ambrosi B; Gaggini M; Secchi F; Faglia G
Horm Metab Res; 1979 Apr; 11(4):318-9. PubMed ID: 222663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
